Frazier Life Sciences Management’s Design Therapeutics DSGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.58M	Hold	1,953,547	–	–	0.26%	42
2025 Q1	$7.54M	Hold	1,953,547	–	–	0.34%	35
2024 Q4	$12.1M	Buy	1,953,547 +61,000	+3%	+$376K	0.5%	33
2024 Q3	$10.2M	Buy	1,892,547 +697,368	+58%	+$3.75M	0.41%	37
2024 Q2	$4M	Buy	+1,195,179	New	+$4M	0.19%	46